Leonardo P. Marcal
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Leonardo P. Marcal has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
- Sireesha Yedururi
The University of Texas MD Anderson Cancer Center
5 shared publications - Ajaykumar C. Morani
The University of Texas MD Anderson Cancer Center, Houston, USA
4 shared publications - Srinivasa R. Prasad
Department of Radiology and Abdominal Imaging, University of Texas, MD Anderson Cancer Center, Houston, TX, USA
4 shared publications - Venkata Subbiah Katabathina
Department of Abdominal Radiology, The University of Texas Health Science Center at San Antonio, San Antonio, USA
4 shared publications - Medhini Rachamallu
Department of Biomedical Engineering, The University of Virginia, Charlottesville, USA
2 shared publications Anand M. Parameswaran
From the Department of Radiology, University of Texas Health at San Antonio, 7703 Floyd Curl Dr, San Antonio, TX 78229 (L.K., A.M.P., V.S.K.); Department of Radiology, University of Texas MD Anderson Cancer Center, Houston, Tex (S.R.P., S.Y., L.P.M.); Department of Radiology, Mayo Clinic, Scottsdale, Ariz (K.S., C.O.M.); and Department of Radiology, University Hospitals Cleveland Medical Center, Cleveland, Ohio (S.H.T.).
1 shared publication
Latest Publications
- 26 July 2025
- Published by Springer Nature in Abdominal Radiology
- Vol. 51 (2) , 1071-1084
Contextual structured annotations on PACS: a futuristic vision for reporting routine oncologic imaging studies and its potential to transform clinical work and research
Radiologists currently have very limited and time-consuming options to annotate findings on the images and are mostly limited to arrows, calipers and lines to annotate any type of findings on most PACS systems. We propose a framework placing encoded, transferable, highly contextual structured text annotations directly on PACS images indicating the type of lesion, level of suspicion, location, lesion measurement, and TNM status for malignant lesions, along with automated integration of this information into the radiology report. This approach offers a one-stop solution to generate radiology reports that are easily understood by other radiologists, patient care providers, patients, and machines while reducing the effort needed to dictate a detailed radiology report and minimizing speech recognition errors. It also provides a framework for automated generation of large volume high quality annotated data sets for machine learning algorithms from daily work of radiologists. Enabling voice dictation of these contextual annotations directly into PACS similar to voice enabled Google search will further enhance the user experience. Wider adaptation of contextualized structured annotations in the future can facilitate studies understanding the temporal evolution of different tumor lesions across multiple lines of treatment and early detection of asynchronous response/areas of treatment failure. We present a futuristic vision, and solution with the potential to transform clinical work and research in oncologic imaging.
- 26 July 2025
- Published by Springer Nature in Abdominal Radiology
- Vol. 51 (2) , 1071-1084
Contextual structured annotations on PACS: a futuristic vision for reporting routine oncologic imaging studies and its potential to transform clinical work and research
Radiologists currently have very limited and time-consuming options to annotate findings on the images and are mostly limited to arrows, calipers and lines to annotate any type of findings on most PACS systems. We propose a framework placing encoded, transferable, highly contextual structured text annotations directly on PACS images indicating the type of lesion, level of suspicion, location, lesion measurement, and TNM status for malignant lesions, along with automated integration of this information into the radiology report. This approach offers a one-stop solution to generate radiology reports that are easily understood by other radiologists, patient care providers, patients, and machines while reducing the effort needed to dictate a detailed radiology report and minimizing speech recognition errors. It also provides a framework for automated generation of large volume high quality annotated data sets for machine learning algorithms from daily work of radiologists. Enabling voice dictation of these contextual annotations directly into PACS similar to voice enabled Google search will further enhance the user experience. Wider adaptation of contextualized structured annotations in the future can facilitate studies understanding the temporal evolution of different tumor lesions across multiple lines of treatment and early detection of asynchronous response/areas of treatment failure. We present a futuristic vision, and solution with the potential to transform clinical work and research in oncologic imaging.
- 1 March 2022
- Published by Radiological Society of North America (RSNA) in RadioGraphics
- Vol. 42 (2) , 417-432
Mesenchymal Neoplasms of the Prostate and Seminal Vesicles: Spectrum of Disease with Radiologic-Pathologic Correlation
To play an effective role in multidisciplinary care of patients, radiologists should understand the rich diversity, pathologic characteristics, and clinical behavior of mesenchymal neoplasms of the... There is a wide spectrum of benign and malignant mesenchymal neoplasms of the prostate, which account for less than 1% of all prostatic tumors. These include distinctive tumors that arise from the ...
- 1 March 2022
- Published by Radiological Society of North America (RSNA) in RadioGraphics
- Vol. 42 (2) , 417-432
Mesenchymal Neoplasms of the Prostate and Seminal Vesicles: Spectrum of Disease with Radiologic-Pathologic Correlation
To play an effective role in multidisciplinary care of patients, radiologists should understand the rich diversity, pathologic characteristics, and clinical behavior of mesenchymal neoplasms of the... There is a wide spectrum of benign and malignant mesenchymal neoplasms of the prostate, which account for less than 1% of all prostatic tumors. These include distinctive tumors that arise from the ...
- 8 May 2021
- Published by Springer Nature in Japanese Journal of Radiology
- Vol. 39 (9) , 825-843
Temporal evolution of metastatic disease: part I—an in-depth review of the evolution of metastatic disease across diverse spectrum of non-neural solid tumors on serial oncologic imaging studies and relevant practical applications
With improved survival rates of patients with metastatic disease due to continuously evolving multimodality treatment options, radiologists are increasingly interpreting imaging studies from patients with protracted metastatic disease. It is thus crucial for radiologists to have an in-depth understanding of the temporal evolution of metastatic spread and the accompanying findings on imaging studies, to provide accurate interpretation that supports optimal management. A general overview of the evolution of cancer spread on serial imaging studies and common pathways of tumor spread across multiple tumor types and tumor locations is not readily available in radiology literature. The key common pathways of tumor spread across diverse spectrum of tumors relevant to radiologists are summarized in a logical schematic approach which focusses on aiding radiologists to understand the pathways of spread resulting in current sites of metastatic disease involvement and then to potentially predict future sites of metastatic involvement. This article also summarizes the practical applications of this knowledge to the routine oncologic imaging interpretation.
- 8 May 2021
- Published by Springer Nature in Japanese Journal of Radiology
- Vol. 39 (9) , 825-843
Temporal evolution of metastatic disease: part I—an in-depth review of the evolution of metastatic disease across diverse spectrum of non-neural solid tumors on serial oncologic imaging studies and relevant practical applications
With improved survival rates of patients with metastatic disease due to continuously evolving multimodality treatment options, radiologists are increasingly interpreting imaging studies from patients with protracted metastatic disease. It is thus crucial for radiologists to have an in-depth understanding of the temporal evolution of metastatic spread and the accompanying findings on imaging studies, to provide accurate interpretation that supports optimal management. A general overview of the evolution of cancer spread on serial imaging studies and common pathways of tumor spread across multiple tumor types and tumor locations is not readily available in radiology literature. The key common pathways of tumor spread across diverse spectrum of tumors relevant to radiologists are summarized in a logical schematic approach which focusses on aiding radiologists to understand the pathways of spread resulting in current sites of metastatic disease involvement and then to potentially predict future sites of metastatic involvement. This article also summarizes the practical applications of this knowledge to the routine oncologic imaging interpretation.
- 4 May 2021
- Published by Springer Nature in Japanese Journal of Radiology
- Vol. 39 (9) , 844-856
Temporal evolution of metastatic disease: part II—a novel proposal for subcategorization of metastatic disease from non-neural solid tumors with diverse histologies and locations
Tumor spread is a continuous process and metastases can further disseminate. Currently, metastatic disease from most primary tumors is subcategorized as M0 if absent and M1 if present. However, metastatic disease in different locations may have different prognostic implications, even if it is from the same primary tumor. The current staging systems for metastatic disease have not evolved to match our understanding of the disease’s evolution or the evolving treatment paradigms. Primary tumor-specific subcategorization of metastatic disease is currently available for a few tumors, but not all of them imply further remote spread of tumor, similar to tumor (T) and N (node) subcategorizations of the TNM staging, nor are they applicable to wide spectrum of other tumors. In this era of precision medicine, tumor-type agnostic therapies based on common biomarkers rather than primary tumor sites are emerging, but a subcategorization system applicable to metastatic disease from diverse primary tumor locations and with diverse histologies is not available. In this article, we discuss the need to further classify the metastatic disease and present a subcategorization applicable to metastatic disease from non-neural solid tumors from different primary tumor sites and with different histologies, which is based on the temporal spread of metastatic disease. Our proposed subcategorization scheme for metastatic disease into M0, M1, M2 and M3, is universally applicable to a diverse spectrum of non-neural solid tumors, and increasing M subcategorization represents further remote spread of tumor.
- 4 May 2021
- Published by Springer Nature in Japanese Journal of Radiology
- Vol. 39 (9) , 844-856
Temporal evolution of metastatic disease: part II—a novel proposal for subcategorization of metastatic disease from non-neural solid tumors with diverse histologies and locations
Tumor spread is a continuous process and metastases can further disseminate. Currently, metastatic disease from most primary tumors is subcategorized as M0 if absent and M1 if present. However, metastatic disease in different locations may have different prognostic implications, even if it is from the same primary tumor. The current staging systems for metastatic disease have not evolved to match our understanding of the disease’s evolution or the evolving treatment paradigms. Primary tumor-specific subcategorization of metastatic disease is currently available for a few tumors, but not all of them imply further remote spread of tumor, similar to tumor (T) and N (node) subcategorizations of the TNM staging, nor are they applicable to wide spectrum of other tumors. In this era of precision medicine, tumor-type agnostic therapies based on common biomarkers rather than primary tumor sites are emerging, but a subcategorization system applicable to metastatic disease from diverse primary tumor locations and with diverse histologies is not available. In this article, we discuss the need to further classify the metastatic disease and present a subcategorization applicable to metastatic disease from non-neural solid tumors from different primary tumor sites and with different histologies, which is based on the temporal spread of metastatic disease. Our proposed subcategorization scheme for metastatic disease into M0, M1, M2 and M3, is universally applicable to a diverse spectrum of non-neural solid tumors, and increasing M subcategorization represents further remote spread of tumor.
- 1 May 2021
- Published by Radiological Society of North America (RSNA) in RadioGraphics
- Vol. 41 (3) , 876-894
Second Malignancies after Radiation Therapy: Update on Pathogenesis and Cross-sectional Imaging Findings
Second malignancies after radiation therapy are dreaded long-term complications of therapeutic radiation exposure, and radiologists should be aware of the spectrum of cancers and their imaging find... A wide spectrum of second cancers occur as late complications of radiation therapy (RT) used to treat various malignancies. In addition to the type and dose of radiation, lifestyle, environmental, ...
- 1 May 2021
- Published by Radiological Society of North America (RSNA) in RadioGraphics
- Vol. 41 (3) , 876-894
Second Malignancies after Radiation Therapy: Update on Pathogenesis and Cross-sectional Imaging Findings
Second malignancies after radiation therapy are dreaded long-term complications of therapeutic radiation exposure, and radiologists should be aware of the spectrum of cancers and their imaging find... A wide spectrum of second cancers occur as late complications of radiation therapy (RT) used to treat various malignancies. In addition to the type and dose of radiation, lifestyle, environmental, ...
- 24 April 2019
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 92 (1098) , 20180478
Tumor thrombus in the venous drainage pathways of primary, recurrent and metastatic disease on routine oncologic imaging studies: beyond hepatocellular and renal cell carcinomas
Radiologists routinely evaluate for tumor thrombus in the portal and hepatic veins in patients with hepatocellular carcinoma and in the renal vein and inferior vena cava in patients with renal cell...
- 24 April 2019
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 92 (1098) , 20180478
Tumor thrombus in the venous drainage pathways of primary, recurrent and metastatic disease on routine oncologic imaging studies: beyond hepatocellular and renal cell carcinomas
Radiologists routinely evaluate for tumor thrombus in the portal and hepatic veins in patients with hepatocellular carcinoma and in the renal vein and inferior vena cava in patients with renal cell...
- 3 January 2019
- Published by Georg Thieme Verlag KG in Digestive Disease Interventions
- Vol. 03 (01) , 014-029
Abdominal Manifestations of Neuroendocrine Tumors
Despite being rare, the incidence and prevalence of gastroenteropancreatic neuroendocrine tumors (NETs) is rising. They are a heterogeneous group of tumors with differences in clinical presentations, genetics, and imaging features. Advances in pathological classification, imaging (including recent radiotracer approval for functional imaging in the Unites States), and therapy have impacted management of these tumors. It is important in the multidisciplinary approach to patient care to be familiar with the tumor biology, imaging techniques for diagnosis and staging, and therapeutic options. This article will discuss these new developments, particularly focusing on pancreatic and small bowel NETs.
- 3 January 2019
- Published by Georg Thieme Verlag KG in Digestive Disease Interventions
- Vol. 03 (01) , 014-029
Abdominal Manifestations of Neuroendocrine Tumors
Despite being rare, the incidence and prevalence of gastroenteropancreatic neuroendocrine tumors (NETs) is rising. They are a heterogeneous group of tumors with differences in clinical presentations, genetics, and imaging features. Advances in pathological classification, imaging (including recent radiotracer approval for functional imaging in the Unites States), and therapy have impacted management of these tumors. It is important in the multidisciplinary approach to patient care to be familiar with the tumor biology, imaging techniques for diagnosis and staging, and therapeutic options. This article will discuss these new developments, particularly focusing on pancreatic and small bowel NETs.
- 13 March 2015
- Published by Springer Nature in European Radiology
- Vol. 25 (9) , 2797-2804
Nosocomial rapidly growing mycobacterial infections following laparoscopic surgery: CT imaging findings
To identify the distribution and frequency of computed tomography (CT) findings in patients with nosocomial rapidly growing mycobacterial (RGM) infection after laparoscopic surgery. A descriptive retrospective study in patients with RGM infection after laparoscopic surgery who underwent CT imaging prior to initiation of therapy. The images were analyzed by two radiologists in consensus, who evaluated the skin/subcutaneous tissues, the abdominal wall, and intraperitoneal region separately. The patterns of involvement were tabulated as: densification, collections, nodules (≥1.0 cm), small nodules ( Twenty-six patients met the established criteria. The subcutaneous findings were: densification (88.5 %), small nodules (61.5 %), small pseudocavitated nodules (23.1 %), nodules (38.5 %), pseudocavitated nodules (15.4 %), and collections (26.9 %). The findings in the abdominal wall were: densification (61.5 %), pseudocavitated nodules (3.8 %), and collections (15.4 %). The intraperitoneal findings were: densification (46.1 %), small nodules (42.3 %), nodules (15.4 %), and collections (11.5 %). Subcutaneous CT findings in descending order of frequency were: densification, small nodules, nodules, small pseudocavitated nodules, pseudocavitated nodules, and collections. The musculo-fascial plane CT findings were: densification, collections, and pseudocavitated nodules. The intraperitoneal CT findings were: densification, small nodules, nodules, and collections. • Rapidly growing mycobacterial infection may occur following laparoscopy. • Post-laparoscopy mycobacterial infection CT findings are densification, collection, and nodules. • Rapidly growing mycobacterial infection following laparoscopy may involve the peritoneal cavity. • Post-laparoscopy rapidly growing mycobacterial intraperitoneal infection is not associated with ascites or lymphadenopathy.
- 13 March 2015
- Published by Springer Nature in European Radiology
- Vol. 25 (9) , 2797-2804
Nosocomial rapidly growing mycobacterial infections following laparoscopic surgery: CT imaging findings
To identify the distribution and frequency of computed tomography (CT) findings in patients with nosocomial rapidly growing mycobacterial (RGM) infection after laparoscopic surgery. A descriptive retrospective study in patients with RGM infection after laparoscopic surgery who underwent CT imaging prior to initiation of therapy. The images were analyzed by two radiologists in consensus, who evaluated the skin/subcutaneous tissues, the abdominal wall, and intraperitoneal region separately. The patterns of involvement were tabulated as: densification, collections, nodules (≥1.0 cm), small nodules ( Twenty-six patients met the established criteria. The subcutaneous findings were: densification (88.5 %), small nodules (61.5 %), small pseudocavitated nodules (23.1 %), nodules (38.5 %), pseudocavitated nodules (15.4 %), and collections (26.9 %). The findings in the abdominal wall were: densification (61.5 %), pseudocavitated nodules (3.8 %), and collections (15.4 %). The intraperitoneal findings were: densification (46.1 %), small nodules (42.3 %), nodules (15.4 %), and collections (11.5 %). Subcutaneous CT findings in descending order of frequency were: densification, small nodules, nodules, small pseudocavitated nodules, pseudocavitated nodules, and collections. The musculo-fascial plane CT findings were: densification, collections, and pseudocavitated nodules. The intraperitoneal CT findings were: densification, small nodules, nodules, and collections. • Rapidly growing mycobacterial infection may occur following laparoscopy. • Post-laparoscopy mycobacterial infection CT findings are densification, collection, and nodules. • Rapidly growing mycobacterial infection following laparoscopy may involve the peritoneal cavity. • Post-laparoscopy rapidly growing mycobacterial intraperitoneal infection is not associated with ascites or lymphadenopathy.
- 26 December 2014
- Published by Springer Nature
- p. 99-111
Magnetic Resonance Imaging for the Diagnosis of Female Genital Anomalies
- 26 December 2014
- Published by Springer Nature
- p. 99-111
Magnetic Resonance Imaging for the Diagnosis of Female Genital Anomalies